Amdt Holdings, Inc.

Amdt Holdings, Inc. specializes in two primary categories of orthopaedic devices: single-use external orthopaedic fixation systems and non-bioabsorbable orthopaedic bone pins. The external fixation systems, such as the Mini-Rail and SixFix Circular Fixation System, are designed to stabilize fractures and deformities externally. Meanwhile, the non-bioabsorbable bone pins are used internally during surgery to align and secure bone fragments. These devices are tailored for orthopaedic applications requiring precise stabilization.

Amdt Holdings, Inc. is based in the United States, which means its devices are subject to FDA regulations. Since the company’s products fall under Class II classification, they undergo a premarket notification (510(k)) process to demonstrate substantial equivalence to a legally marketed predicate device. Additionally, the FDA’s Unique Device Identifier (UDI) system applies, ensuring traceability and compliance tracking for these authorised devices.

Amdt Holdings, Inc.’s devices are listed in the FDA’s 510(k) premarket notification database and the FDA’s Unique Device Identifier (UDI) system. These registries serve as official records of authorised devices, where the 510(k) pathway confirms compliance with FDA requirements for Class II devices, and the UDI system provides a standardized identification system for tracking and monitoring these products in the market.

Amdt Holdings, Inc.’s devices are classified as Class II under FDA regulations, which means they pose moderate risk and require special controls to ensure safety and effectiveness. This classification necessitates premarket submission through the 510(k) pathway, where the company must demonstrate that their devices are substantially equivalent to a legally marketed predicate device. The classification ensures that these orthopaedic fixation systems and bone pins meet rigorous standards before entering the market.